Jason Aryeh

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD.

CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA.

JALAA Equities LP is an independent hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded by Jason Aryeh in 1997 and manages assets of high net worth clients.

Part of Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc. engages in drug discovery and development. The private company is based in Bethesda, MD.